ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00440609
Recruitment Status : Completed
First Posted : February 27, 2007
Last Update Posted : August 2, 2013
Sponsor:
Information provided by (Responsible Party):
Philip J. ferrone, M.D., Long Island Vitreoretinal Consultants

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : December 2012

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 30, 2015 April 10, 2015
2 March 17, 2016 April 18, 2016
3 August 24, 2017 September 20, 2017
4 September 25, 2017 October 23, 2017